Find Clinical Trials | Cedars-Sinai

438 results found

Other

MOVE Registry

The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROLTM VENOUS VCD 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures ...

Other

Inhibikase_IKT-001-201_A Phase 2b Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)

To evaluate the effect on pulmonary vascular resistance (PVR) in participants with PAH and World Health Organization Functional Class (WHO FC) II-III symptoms treated with IKT-001 compared to placebo. To assess the safety and tolerability of ...

Other Hematopoietic

Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Amyloid Light Chain Amyloidosis

This study focuses on people who have amyloid light chain amyloidosis (AL amyloidosis) and are not able to receive a type of stem cell transplant, which can be a treatment for some people with AL ...

Other

CareDx_UroMap

Whether UroMap can be used to identify patients that need a biopsy from those that may not need one, in setting of BKVAN or rejection. Specifically, can UroMap be added as an additional test to ...

Lymphoid Leukemia

Nurix Therapeutics, Inc., NX-5948-201, Ph 2, open-label, CLL, NX-5948

Primary Objective: To evaluate the efficacy of NX-5948 in adults with R/R CLL/SLL previously exposed to a cBTKi, a ncBTKi, and a BCL-2i in accordance with iwCLL guidelines (Hallek 2018) Secondary Objectives: To further evaluate the efficacy of ...